Literature DB >> 14658300

[Memory and potassium channels].

E I Solntseva1, Iu V Bukanova, V G Skrebitskiĭ.   

Abstract

The K(+)-channels of the surface membrane play a crucial role in the generation of electrical activity of a neuron. There is a large diversity of the K(+)-channels that depends on a great number (over 200) of genes encoding channels proteins. An evolutionary conservation of channel's proteins is determined. The K(+)-channels were found to have a great importance in the memory processes. It was shown on different model systems that K(+)-current of the surface membrane decreases during the learning. The antagonists of K(+)-channels were found to improve the learning and memory. It was revealed in electrophysiological experiments that K(+)-channels antagonists can either themselves induce a long-term synaptic potentiation or intensify the synaptic potentiation induced by a tetanization. The disfunction of K(+)-channels is believed to be an important link in the mechanisms of memory disturbances. In animal mutants with K(+)-channels disfunction, learning and memory are deficient. In behavioral experiments, the use of K(+)-channels openers make the learning worse. Amnesia caused by cerebral ischemia is explained by strong activity of K(+)-channels which not only inhibits neuronal excitement but also causes neurodegeneration. The question on the K(+)-channels involvement into pathophysiology of Alzheimer's disease is discussed. Neurotoxic peptide beta-amyloid, which is supposed to be involved into mechanisms of Alzheimer's disease, modulates K(+)-channels function. The effect of beta-amyloid depends on the subtype of K(+)-channels: A-channels are inhibited, and KDR-channels, on the contrary, become stronger. The effect of the cognitive enhancers (vinpocetine, piracetam, tacrine, linopirdine) on K(+)-current also depends on the subtype of K(+)-channels. Slow-inactivating K(+)-currents (IDR, IK(Ca), IM) are inhibited in the presence of these drugs, while fast-in-activating K(+)-current (A-current) remains unchanged or even increases.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14658300

Source DB:  PubMed          Journal:  Usp Fiziol Nauk        ISSN: 0301-1798


  7 in total

1.  Pathogenesis of Human Immunodeficiency Virus Type-1 (HIV-1)-Associated Dementia: Role of Voltage-Gated Potassium Channels.

Authors:  James P Keblesh; Benjamin C Reiner; Jianuo Liu; Huangui Xiong
Journal:  Retrovirology (Auckl)       Date:  2008

Review 2.  Voltage-gated potassium channels in human immunodeficiency virus type-1 (HIV-1)-associated neurocognitive disorders.

Authors:  James Keblesh; Dehui Hu; Huangui Xiong
Journal:  J Neuroimmune Pharmacol       Date:  2008-05-06       Impact factor: 4.147

3.  Involvement of the 4-aminopyridine-sensitive transient A-type K+ current in macrophage-induced neuronal injury.

Authors:  Dehui Hu; Jianuo Liu; James Keblesh; Huangui Xiong
Journal:  Eur J Neurosci       Date:  2010-01-13       Impact factor: 3.386

4.  4-Aminopyridine improves spatial memory in a murine model of HIV-1 encephalitis.

Authors:  James P Keblesh; Huanyu Dou; Howard E Gendelman; Huangui Xiong
Journal:  J Neuroimmune Pharmacol       Date:  2009-05-23       Impact factor: 4.147

5.  Enhancement of neuronal outward delayed rectifier K+ current by human monocyte-derived macrophages.

Authors:  Dehui Hu; Jianuo Liu; Huangui Xiong
Journal:  Glia       Date:  2009-11-01       Impact factor: 7.452

6.  The Relieving Effects of BrainPower Advanced, a Dietary Supplement, in Older Adults with Subjective Memory Complaints: A Randomized, Double-Blind, Placebo-Controlled Trial.

Authors:  Jingfen Zhu; Rong Shi; Su Chen; Lihua Dai; Tian Shen; Yi Feng; Pingping Gu; Mina Shariff; Tuong Nguyen; Yeats Ye; Jianyu Rao; Guoqiang Xing
Journal:  Evid Based Complement Alternat Med       Date:  2016-04-11       Impact factor: 2.629

7.  HIV-1 Tat alters neuronal intrinsic excitability.

Authors:  Walter Francesconi; Fulvia Berton; Maria Cecilia G Marcondes
Journal:  BMC Res Notes       Date:  2018-05-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.